The oral drug by Merck & Co. smashes all competitors for the treatment and prevention of atherosclerosis.
ischemic heart disease (IHD)
Posted inCardiology, Metabolism, New Drugs, Rare/Orphan Diseases, Regulatory
Leqvio: Newest Drug Against ‘Very Bad’ Cholesterol
Two injections of inclisiran a year and you can forget about high cholesterol. Novartis doesn’t lie.